Search results for "cost"

showing 10 items of 5421 documents

Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study

2011

Abstract Background and objective An important input to decision-making and health planning is a consistent and comparative description of the population health status. The purpose of this study was to describe the burden of disease in the Region of Valencia (Spain). Material and methods Disability-adjusted life years (DALYs) were calculated and divided into years of life lost (YLLs) and years lived with disability (YLDs). Using death registry data and Valencian population estimates in 2008, we calculated the number of deaths and YLLs. YLDs were based on age- and sex-specific data for countries of the EURO-A subregional level (which includes the Region of Valencia) from the Global Burden of…

AdultMaleBurden of diseaseAdolescentSense organHealth StatusPopulationPopulation healthValencianYoung AdultAge DistributionLife ExpectancyCost of IllnessCause of DeathHumansMedicineDisabled PersonsSex DistributionChildeducationDiagnosis-Related GroupsDisease burdenDepression (differential diagnoses)AgedAged 80 and overeducation.field_of_studybusiness.industryInfant NewbornInfantGeneral MedicineMiddle Agedlanguage.human_languageYears of potential life lostSpainChild PreschoolChronic DiseaselanguageFemalebusinessDemographyMedicina Clínica
researchProduct

Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting in…

1995

Background. A single-institution, randomized open trial was prospectively performed to compare orally administered granisetron with or without intramuscularly administered methylprednisolone to metoclopramide plus methylprednisolone in the prevention of delayed nausea and vomiting induced by cisplatin-based chemotherapy. The effects of antiemetic treatments were evaluated from days 2 to 5 of the first cycle after cisplatin administration among patients who had never before received chemotherapy. Methods. All patients were treated with chemotherapeutic regimens containing cisplatin greater than or equal to 80 mg/m 2 and received antiemetic therapy with granisetron 3 mg intravenously for the …

AdultMaleCancer ResearchMetoclopramideNauseamedicine.drug_classMetoclopramideVomitingmedicine.medical_treatmentAdministration OralGranisetronMethylprednisoloneGranisetronNeoplasmsmedicineAntiemeticHumansProspective StudiesAgedChemotherapybusiness.industryNauseaMiddle AgedOncologyMethylprednisoloneAnesthesiaVomitingCorticosteroidAntiemeticsDrug Therapy CombinationFemalemedicine.symptomCisplatinbusinessmedicine.drugCancer
researchProduct

Efficacy of mometasone furoate microemulsion in the treatment of erosive-ulcerative oral lichen planus: pilot study

2004

Background:  Oral lichen planus (OLP) is a frequent immunological chronic disease, having different clinical forms: asymptomatic and symptomatic. Symptomatic OLP has been palliated with topical corticosteroids with different levels of efficacy and safety. The purpose of this pilot phase II clinical trial was to determine the efficacy of mometasone furoate microemulsion upon the symptoms and signs of erosive-ulcerative OLP. Methods:  Forty-nine patients with clinical and histologically confirmed erosive-ulcerative OLP were enrolled in this study (36 women and 13 men). Their average age was 56.4 years (from 28 to 78). The treatment consisted of 0.1% mometasone furoate microemulsion mouthwash …

AdultMaleCancer Researchmedicine.medical_specialtyErythemamedicine.drug_classAdministration TopicalAnti-Inflammatory AgentsMouthwashesMometasone furoatePilot ProjectsAsymptomaticPathology and Forensic Medicinestomatognathic systemHumansMedicineAdverse effectGlucocorticoidsPregnadienediolsAgedbusiness.industryMometasoneMiddle Agedmedicine.diseaseDermatologyClinical trialstomatognathic diseasesOtorhinolaryngologyPeriodonticsCorticosteroidEmulsionsFemaleOral lichen planusOral Surgerymedicine.symptombusinessMometasone FuroateLichen Planus Oralmedicine.drugJournal of Oral Pathology and Medicine
researchProduct

Health science student teachers' perceptions of teacher competence: A qualitative study.

2019

Abstract Background Health science teacher competence is multifaceted and continuously changing according to national and international healthcare standards. Organizational restructuring and emphasis on cost effectiveness is changing the scope of health science teachers' practical work and their role in healthcare (worldwide). Aim This study aimed to describe student teachers' perceptions of the competencies needed to work as an educator in the healthcare field. Objective of study was to gain new knowledge which can be used in the development of teacher education programs in nursing science and to define a broader definition of the health science educators. Methods A qualitative study was c…

AdultMaleCost effectivenessEducation03 medical and health sciences0302 clinical medicineHealth careComputingMilieux_COMPUTERSANDEDUCATIONHumans030212 general & internal medicineStudentsCurriculumCompetence (human resources)Health EducationGeneral NursingFinlandQualitative ResearchMedical education030504 nursingbusiness.industryFocus GroupsMiddle AgedFocus groupFacultyTeacher educationContent analysisFemalePerception0305 other medical sciencebusinessPsychologyQualitative researchNurse education today
researchProduct

Long-term cost-effectiveness of cognitive behavioral therapy versus psychodynamic therapy in social anxiety disorder.

2015

Background To determine the cost-effectiveness of cognitive behavioral therapy (CBT) versus psychodynamic therapy (PDT) in the treatment of social anxiety disorder after a follow-up of 30 months from a societal perspective. Methods This analysis was conducted alongside the multicenter SOPHO-NET trial; adults with a primary diagnosis of social anxiety disorder received CBT (n = 209) or PDT (n = 207). Data on health care utilization and productivity loss were collected at baseline, after 6 months (posttreatment), and three further follow-ups to calculate direct and indirect costs. Anxiety-free days (AFDs) calculated based on remission and response were used as measure of effect. The increment…

AdultMaleCost effectivenessmedicine.medical_treatmentCost-Benefit AnalysisTime03 medical and health sciencesIndirect costs0302 clinical medicineWillingness to paymedicineHumanshealth care economics and organizationsPsychodynamic psychotherapyCost–benefit analysisCognitive Behavioral TherapySocial anxietyPhobia Social3. Good health030227 psychiatryCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyTreatment OutcomeCognitive therapyFemalePsychologyPsychotherapy Psychodynamic030217 neurology & neurosurgeryClinical psychologyDepression and anxiety
researchProduct

Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year r…

2009

BackgroundEmpirical evidence of the efficacy and effectiveness of psychosocial family intervention and of the specificity of its effects on the course of schizophrenia is limited. The aim was to study the efficacy and effectiveness of psychosocial family intervention with regard to clinical and social functioning and family burden after controlling for compliance and several prognostic factors.MethodA 2-year randomized controlled trial with blind assessments. Fifty patients with DSM-IV schizophrenia and persistent positive symptoms and/or previous clinical relapse were allocated to psychosocial family intervention, individual counselling and standard treatment versus individual counselling …

AdultMaleFamily therapymedicine.medical_specialtylaw.inventionYoung AdultCost of IllnessRandomized controlled triallawIntervention (counseling)Secondary PreventionmedicineHumansSchizophreniform disorderPsychiatryApplied PsychologyPsychiatric Status Rating ScalesStandard treatmentSocial environmentmedicine.diseaseCombined Modality TherapyPsychotherapyPsychiatry and Mental healthTreatment OutcomeCaregiversPsychotic DisordersSpainSchizophreniaSchizophreniaPatient ComplianceFamily TherapyFemaleSchizophrenic PsychologyPsychologySocial AdjustmentPsychosocialAntipsychotic AgentsPsychological Medicine
researchProduct

Barriers to physical activity in university students with disabilities: Differences by sociodemographic variables

2019

Abstract Background Despite the positive effects of regular physical activity (PA), university students with disabilities are less active than their able-bodied peers, which could be due to the wide range of barriers to PA that these individuals face across all social ecological levels. Objective To identify the barriers to PA experienced by university students with disabilities at the different social ecological levels and to examine the differences in these barriers by sociodemographic variables. Methods The reduced Spanish version of the Barriers to Physical Activity Questionnaire for People with Mobility Impairments was administered to a sample of 1219 Spanish university students with d…

AdultMaleGerontologyAdolescentUniversitiesMultiple disabilitiesmedia_common.quotation_subjectPhysical activityPainFriendsInterpersonal communicationEnvironmentMotor ActivitySocial EnvironmentYoung Adult03 medical and health sciences0302 clinical medicinePromotion (rank)Economic costHumansDisabled PersonsFamily030212 general & internal medicineStudentsExerciseFatiguemedia_commonMotivationCommunity levelPublic Health Environmental and Occupational HealthArchitectural AccessibilityGeneral MedicineMiddle AgedSocial ecological modelFemalePsychology030217 neurology & neurosurgeryIntrapersonal communicationDisability and Health Journal
researchProduct

Measuring the burden of disease and injury in Spain using disability-adjusted life years: An updated and policy-oriented overview

2011

Summary Objective To provide a comprehensive and detailed overview of the burden of disease in Spain for 2008. Implications for public health policies are discussed. Study design Cross-sectional population-based study. Methods Disability-adjusted life years (DALYs) were calculated at country level using the methodology developed in the Global Burden of Disease study. DALYs were divided into years of life lost and years of life lived with disability. Results were obtained using Spanish mortality data for 2008 and morbidity data estimated previously by the World Health Organization for Euro-A. Results In 2008, DALYs lost due to all diseases and injuries were estimated at 5.1 million. Non-comm…

AdultMaleGerontologymedicine.medical_specialtyAdolescentCross-sectional studyPopulationPopulation healthYoung AdultCost of IllnessCause of DeathEnvironmental healthHumansMedicineDisabled PersonsChildeducationHealth policyDepression (differential diagnoses)Agededucation.field_of_studybusiness.industryHealth PolicyPublic healthPublic Health Environmental and Occupational HealthInfantGeneral MedicineMiddle AgedQuality-adjusted life yearCross-Sectional StudiesYears of potential life lostSpainChild PreschoolWounds and InjuriesFemaleQuality-Adjusted Life YearsbusinessPublic Health
researchProduct

Editor's Note: Relates to: ‘Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to p…

2020

Aims The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD). Methods and results Of the theoretical estimated prevalence of 1/500 for heterozygous FH, <1% are diagnosed in most countries. Recently, direct screening in a Northern European general population diagnosed approximately 1/200 with heterozygous FH. All reported studies document failure to achieve recommended LDL cholesterol targets in a large proportion of individuals with FH, and up to 13-fold increased risk of CHD. Based on prevalen…

AdultMaleHeterozygoteConsensusCost-Benefit AnalysisCoronary DiseaseRisk AssessmentHyperlipoproteinemia Type IIHumansAcademicSubjects/MED00200ChildAnticholesteremic AgentsLow-density lipoproteinHomozygoteCholesterol LDLMiddle AgedCardiovascular diseaseAtherosclerosisCorrigendaPedigreeCoronary heart diseaseCholesterolEarly DiagnosisTreatment OutcomeCurrent OpinionChild PreschoolMutationFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsDelivery of Health CareForecastingEuropean Heart Journal
researchProduct

Mycobacterial Infection: A Difficult and Late Diagnosis in Stem Cell Transplant Recipients

2004

The Infectious Diseases Working Party of the European Blood and Marrow Transplant Group conducted a survey to obtain information about the frequency, presentation, and treatment of mycobacterial infection (MBI) in stem cell transplant (SCT) recipients. Among 29 centers, MBI was diagnosed in 0.79% of 1513 allogeneic and 0.23% of 3012 autologous SCT recipients during 1994-1998 a median of 160 days after transplantation. The mean interval between first symptoms and diagnosis was 29 days and was still longer for patients with atypical MBI or recipients of corticosteroid therapy. The prevalence of MBI was highest among those who received matched unrelated or mismatched STCs from related donors. …

AdultMaleMicrobiology (medical)medicine.medical_specialtyTuberculosisAdolescentmedicine.drug_classmedicine.medical_treatmentHematopoietic stem cell transplantationOpportunistic InfectionsInternal medicineEpidemiologymedicineHumansTuberculosisChildRetrospective StudiesMycobacterium Infectionsbusiness.industryIncidenceHematopoietic Stem Cell TransplantationMiddle Agedmedicine.diseaseSurgeryTransplantationsurgical procedures operativeInfectious Diseasesmedicine.anatomical_structureLate diagnosisChild PreschoolCorticosteroidFemaleBone marrowStem cellbusinessStem Cell TransplantationClinical Infectious Diseases
researchProduct